CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis.
about
Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosisOxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolaseToward biomarkers in multiple sclerosis: new advances.Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.Pathogenic CD8 T cells in multiple sclerosis and its experimental models.Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.Characterization of mature rat oligodendrocytes: a proteomic approach.
P2860
Q33535660-82549C0C-5DDE-4186-A62C-5543C3BCF15CQ33625425-C0079791-D4A9-48D6-B396-40675AE4184CQ33886414-D76EDE15-C016-4A36-A950-C94D3F7B610AQ34139182-32D94C0D-3344-46C8-8088-E9327724B010Q34612943-273D8BEF-71DA-412B-8547-93E1CB636E6FQ35048149-1D624080-0E72-4CCA-AA41-589A2E230712Q36492380-28016CB6-4D56-47AE-87C9-58BE3A4D3944Q36508891-48800970-5A4A-4743-98FF-D57B9A294897Q36771875-175A789F-E6F8-419B-B696-B32FF5436B72Q37313736-AE4C4116-9EBA-4CA4-A7F4-BC90684F10E0Q38008365-0447C2BE-CAE1-4166-8ECC-B3E591FE19E9Q43147458-917A93B4-A179-4DFC-9805-F8C441B9570CQ43806788-85FD380D-71DE-4EFB-B5FE-496BDF2F607EQ48198699-BE189DFD-E62F-46F1-9CD2-58AD2F4D6144
P2860
CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@ast
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@en
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@nl
type
label
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@ast
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@en
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@nl
prefLabel
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@ast
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@en
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@nl
P2093
P1476
CD8+ T cell-mediated HLA-A*020 ...... ients with multiple sclerosis.
@en
P2093
Brian Niland
Katalin Banki
William E Biddison
P304
P356
10.4049/JIMMUNOL.175.12.8365
P407
P50
P577
2005-12-01T00:00:00Z